The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment outcome and functional characterization of uncommon EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM).
 
Melanie Janning
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Amgen; Chugai Pharma; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Roche
 
Juliane Sueptitz
No Relationships to Disclose
 
Anika Forstreuter
No Relationships to Disclose
 
Corinna Albers-Leischner
No Relationships to Disclose
 
Amanda Tufman
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; MSD; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Celgene (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; MSD; Pfizer; Roche; Takeda
 
Janna-Lisa Velthaus-Rusik
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Lilly
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Andreas Jung
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Biocartis; Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; QuiP; Roche; Thermo Fisher Scientific
Speakers' Bureau - Amgen; Archer; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Thermo Fisher Scientific
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Biocartis; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; QuiP; Roche; Thermo Fisher Scientific
 
Irina Bonzheim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Novartis
 
Stephanie Brändlein
No Relationships to Disclose
 
Marcel Wiesweg
Honoraria - Boehringer Ingelheim; Novartis; Roche; Takeda
Consulting or Advisory Role - Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Jan Stratmann
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Novartis; Roche
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Juergen Alt
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb
 
Juliane Limberg
No Relationships to Disclose
 
Felix Carl Saalfeld
Honoraria - Pfizer; Takeda
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Takeda
 
Johannes Berger
Honoraria - Novartis
 
Lars Tögel
No Relationships to Disclose
 
Reinhard Buettner
Employment - Targos GmbH
Leadership - Targos GmbH
Stock and Other Ownership Interests - Targos GmbH
Honoraria - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Illumina; Lilly; MSD; Novartis; Pfizer; Quiagen; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Illumina; Lilly; MSD; Novartis; Pfizer; Quiagen; Roche
 
Juergen Wolf
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Ignyta; Janssen; Lilly; Loxo; MSD; Novartis; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Blueprint Genetics; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Ignyta; Janssen; Lilly; Loxo; MSD; Novartis; Pfizer; Roche; Seagen; Takeda
 
Sonja Loges
Honoraria - Sanofi
Consulting or Advisory Role - Abbvie; AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; Medac; Novartis; Pfizer; Roche Pharma AG; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Medac; Novartis; Pfizer; Roche Pharma AG; Sanofi; Takeda
Research Funding - ADC Therapeutics; BerGenBio; Bristol-Myers Squibb; Lilly; Roche Pharma AG